CAMELLE JONES: Open Payments
NPI 1508356411 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 6 payments from 6 companies in 2025. Trend: 2023 $503 · 2024 $163 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $95 |
| Sumitomo Pharma America, Inc. | 1 | $78 |
| Medtronic, Inc. | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerendia, GEMTESA, COREVALVE EVOLUT R, UPTRAVI, SAPHNELO, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
